CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Jun. 30, 2020	$ 216	$ 24,784	$ (1,000)	$ 24,000
Balance at the beginning (in shares) at Jun. 30, 2020	2,156,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(80)	(80)
Balance at the end at Sep. 30, 2020	$ 216	24,784	(1,080)	23,920
Balance at the end (in shares) at Sep. 30, 2020	2,156,250
Balance at the beginning at Jun. 30, 2020	$ 216	24,784	(1,000)	24,000
Balance at the beginning (in shares) at Jun. 30, 2020	2,156,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(80,623)
Balance at the end at Dec. 31, 2020	$ 256	5,081,375	(81,623)	5,000,008
Balance at the end (in shares) at Dec. 31, 2020	2,564,582
Balance at the beginning at Sep. 30, 2020	$ 216	24,784	(1,080)	23,920
Balance at the beginning (in shares) at Sep. 30, 2020	2,156,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of 8,009,041 Public Shares, net of underwriting discounts and offering costs	$ 801	78,231,111		$ 78,231,912
Sale of 8,009,041 Public Shares, net of underwriting discounts and offering costs (in shares)	8,009,041			8,009,041
Sale of 3,146,454 Private Warrants		2,831,809		$ 2,831,809
Common stock subject to possible redemption	$ (761)	(76,006,329)		(76,007,090)
Common stock subject to possible redemption (in shares)	(7,600,709)
Net loss			(80,543)	(80,543)
Balance at the end at Dec. 31, 2020	$ 256	$ 5,081,375	$ (81,623)	$ 5,000,008
Balance at the end (in shares) at Dec. 31, 2020	2,564,582